The findings revealed an increased ratio of CD4+/CD8+ T lymphocytes, higher frequency of Th17 cells, and a decrease in Treg cells, significantly improving immune function in patients with HCC (Liao et al., 2013; Liao et al., 2015). The gene discussed is CD4; the disease is hepatocellular carcinoma.